Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005092125 | SCV002779277 | uncertain significance | Ocular cystinosis; Juvenile nephropathic cystinosis; Nephropathic cystinosis | 2022-04-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002535025 | SCV003483298 | uncertain significance | Ocular cystinosis; Juvenile nephropathic cystinosis; Inborn genetic diseases | 2022-02-06 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 256 of the CTNS protein (p.Ala256Leu). Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This variant has not been reported in the literature in individuals affected with CTNS-related conditions. ClinVar contains an entry for this variant (Variation ID: 591047). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gharavi Laboratory, |
RCV000722223 | SCV000853354 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research |